BIOMÉRIEUX DENMARK ApS: Financial statements 2022
CVR: 10062462
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BIOMÉRIEUX DENMARK ApS (CVR 10062462) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 65,119,267 and a net result of DKK 3,632,278 compared with DKK 4,965,504 the year before. That is a decrease of 16.1% compared with the year before. The profit margin was 5.6%. Equity in the 2022 report amounted to DKK 13,671,725. The solvency ratio was 54%. The company had 9 employees in the financial year.
- Revenue
- DKK 65,119,267
- Gross Profit
- DKK 12,445,181
- Profit/Loss
- DKK 3,632,278
- Equity
- DKK 13,671,725
- Total Assets
- DKK 25,340,857
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 65.1M | 12.4M | 3.6M | 13.7M | 9 |
| 2021 | 77.6M | 14.7M | 5M | 12.3M | 10 |
| 2020 | 68.3M | 12.8M | 3.3M | 9.5M | 10 |
| 2019 | 65.1M | 11.4M | 2.6M | 8.4M | 10 |
| 2018 | 59.3M | 10.4M | 3M | 8.8M | 8 |
Official annual report
Keep an eye on BIOMÉRIEUX DENMARK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BIOMÉRIEUX DENMARK ApS has published its annual report for 2021. Revenue came to DKK 77,639,173, and the net result was DKK 4,965,504.
As of April 6, 2022, Pascal Jean D Waucquez has joined the board of directors of BIOMÉRIEUX DENMARK ApS.
As of April 6, 2022, Rocio Mendez Aleman has left the board of directors of BIOMÉRIEUX DENMARK ApS.
As of April 6, 2022, Pascal Jean D Waucquez is registered as adm. dir. of BIOMÉRIEUX DENMARK ApS.
As of April 6, 2022, Rocio Mendez Aleman has stepped down as adm. dir. of BIOMÉRIEUX DENMARK ApS.
About BIOMÉRIEUX DENMARK ApS
BIOMÉRIEUX DENMARK ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2001. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named GFKJUS 623 ApS. The management consists of Denis Bernard Monnaie. The board consists of Denis Bernard Monnaie (chair), Bertrand Playe and Urszula Maria Leśniak. The company is owned by bioMerieux SA. The company has 9 employees (2026). In 2025, the company reported revenue of DKK 73,353,462 and a net result of DKK 2,225,144 compared with DKK 2,749,222 the year before. Equity in the 2025 report amounted to DKK 6,678,762.